This site is intended for health professionals only
Wednesday 22 August 2018
Share |

Zilico Ltd cervical cancer diagnostics tool

Related articles

The CHMP has given a positive opinion recommending Novartis’s Kymriah (tisagenlecleucel) to treat two aggressive blood cancers.
First patient with metastatic breast cancer receives treatment to look at anti-tumour effect and tolerability using new drug response predictor
A report from the charity Cancer Research UK has called on the health service to prepare for a large increase in the number of over 75s with cancer
Manufacturer Amgen has received approval from the European Commission (EC) to include overall survival (OS) data on the labels of the drug BLINCYTO (blinatumomab), it has announced.
Zilico Ltd will present its pioneering cervical cancer diagnostics tool at Medica 2012 - the world’s premier healthcare exhibition.
The British company’s innovative system, which is due to be launched in 2013, offers quicker more accurate detection of cervical dysplasia in real time, removing several weeks of waiting time for diagnosis.

Ads by Google